Due to renovations at our Patroon Creek office, the regular entrance in the lower lot is CLOSED. Patients (including those from our Troy and Albany Medical Center locations) must use the upper lot entrance for Suite 210 and 211. However, Radiation, PET and CT imaging patients can use our separate Radiation Entrance in the lower lot. Learn More

About Us

Dr. Shaffer recognized for genitourinary cancer research

2/27/2020

The US Oncology Network recently recognized Dr. David Shaffer for enrolling the highest number of genitourinary cancers patients in clinical research trials, among more than 1,200 physicians in member practices across the country.

Dr. Shaffer currently serves as chief investigator for GU cancers (prostate, bladder and renal cell) in New York Oncology Hematology’s clinical research program. He was recognized at the US Oncology Network Research Annual Science Forum.

Over the past 25 years, New York Oncology Hematology patients have participated in clinical drug trials leading to FDA approval of 49 new cancer therapies. NYOH is the largest organization in the area that participates in Phase I/II and III trials, including those for all major solid tumor types, hematologic malignancies and supportive care.

Watch a video about clinical trials at NYOH

Full list of available trials